Detalles de la búsqueda
1.
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia.
Blood Adv;
8(9): 2094-2103, 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38295280
2.
A Pilot Study of Low-Dose Craniospinal Irradiation in Patients With Newly Diagnosed Average-Risk Medulloblastoma.
Front Oncol;
11: 744739, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34540703
3.
Genomic Variants of Cytarabine Sensitivity Associated with Treatment-Related Mortality in Pediatric AML: A Report from the Children's Oncology Group.
Clin Cancer Res;
26(12): 2891-2897, 2020 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32122921
4.
Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial.
Lancet Oncol;
18(1): 63-74, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27914822
5.
Robert J. Arceci, MD, PhD, 1950-2015.
Pediatr Blood Cancer;
62(8): i-ii, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26089131
6.
Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors.
J Natl Cancer Inst;
106(8)2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25080574
7.
NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report.
Blood;
124(15): 2400-7, 2014 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25145343
8.
Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology Group.
Br J Haematol;
166(2): 254-259, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24661089
9.
Proactive enteral tube feeding in pediatric patients undergoing chemotherapy.
Pediatr Blood Cancer;
61(2): 281-5, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24019241
10.
Comparable survival for pediatric acute myeloid leukemia with poor-risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation.
Pediatr Blood Cancer;
61(2): 269-75, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23955900
11.
BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Pediatr Blood Cancer;
61(4): 647-52, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24127439
12.
Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology Group.
Cancer;
119(23): 4162-9, 2013 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24104395
13.
Outcome of pediatric patients with acute myeloid leukemia (AML) and -5/5q- abnormalities from five pediatric AML treatment protocols: a report from the Children's Oncology Group.
Pediatr Blood Cancer;
60(12): 2073-8, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24039149
14.
FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report.
Blood;
121(7): 1083-93, 2013 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-23243289
15.
Patients with Fanconi anemia and AML have different cytogenetic clones than de novo cases of AML.
Pediatr Blood Cancer;
59(5): 922-4, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22517793
16.
Germline genetic variation and treatment response on CCG-1891.
Pediatr Blood Cancer;
58(5): 695-700, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21618417
17.
Superior outcome of pediatric acute myeloid leukemia patients with orbital and CNS myeloid sarcoma: a report from the Children's Oncology Group.
Pediatr Blood Cancer;
58(4): 519-24, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21618422
18.
Estimation of the prevalence of Fanconi anemia among patients with de novo acute myelogenous leukemia who have poor recovery from chemotherapy.
Leuk Res;
36(1): 29-31, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21974856
19.
Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia.
Pediatr Blood Cancer;
57(3): 398-405, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21681921
20.
Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia.
Blood;
117(26): 7007-13, 2011 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-21518931